Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Watson, Stuart
and
Young, Allan Hunter
2001.
The place of lithium salts in psychiatric practice 50 years on.
Current Opinion in Psychiatry,
Vol. 14,
Issue. 1,
p.
57.
Young, Allan H
Hughes, John H
Marsh, V.Richard
and
Ashton, C.Heather
2002.
Acute tryptophan depletion attenuates auditory event related potentials in bipolar disorder: a preliminary study.
Journal of Affective Disorders,
Vol. 69,
Issue. 1-3,
p.
83.
Young, Simon N.
and
Leyton, Marco
2002.
The role of serotonin in human mood and social interaction.
Pharmacology Biochemistry and Behavior,
Vol. 71,
Issue. 4,
p.
857.
Booij, L
Van der Does, A J W
and
Riedel, W J
2003.
Monoamine depletion in psychiatric and healthy populations: review.
Molecular Psychiatry,
Vol. 8,
Issue. 12,
p.
951.
Bell, Caroline J.
Hood, Sean D.
and
Nutt, David J.
2005.
Acute Tryptophan Depletion. Part II: Clinical Effects and Implications.
Australian & New Zealand Journal of Psychiatry,
Vol. 39,
Issue. 7,
p.
565.
Yatham, Lakshmi N
Liddle, Peter F
Lam, Raymond W
Adam, Michael J
Solomons, Kevin
Chinnapalli, Manjunath
and
Ruth, Thomas J
2005.
A positron emission tomography study of the effects of treatment with valproate on brain 5‐HT2A receptors in acute mania.
Bipolar Disorders,
Vol. 7,
Issue. s5,
p.
53.
Bell, Caroline J.
Hood, Sean D.
and
Nutt, David J.
2005.
Acute Tryptophan Depletion. Part II: Clinical Effects and Implications.
Australian & New Zealand Journal of Psychiatry,
Vol. 39,
Issue. 7,
p.
565.
Young, Allan H.
and
Newham, James I.
2006.
Lithium in maintenance therapy for bipolar disorder.
Journal of Psychopharmacology,
Vol. 20,
Issue. 2_suppl,
p.
17.
Applebaum, Julia
Bersudsky, Yuly
and
Klein, Ehud
2007.
Rapid tryptophan depletion as a treatment for acute mania: a double‐blind, pilot‐controlled study.
Bipolar Disorders,
Vol. 9,
Issue. 8,
p.
884.
Porter, Richard J.
Gallagher, Peter
and
O’Brien, John T.
2007.
Effects of rapid tryptophan depletion on salivary cortisol in older people recovered from depression, and the healthy elderly.
Journal of Psychopharmacology,
Vol. 21,
Issue. 1,
p.
71.
JohnMann, J.
and
Currier, Dianne
2007.
Bipolar Disorder: Basic Mechanisms and Therapeutic Implications.
p.
89.
Dougherty, Donald M.
Marsh-Richard, Dawn M.
Mathias, Charles W.
Hood, Ashley J.
Addicott, Merideth A.
Moeller, F. Gerard
Morgan, Christopher J.
and
Badawy, Abdulla A.-B.
2008.
Comparison of 50- and 100-g l-tryptophan depletion and loading formulations for altering 5-HT synthesis: pharmacokinetics, side effects, and mood states.
Psychopharmacology,
Vol. 198,
Issue. 3,
p.
431.
Harrison-Read, PE
2009.
Antimanic potency of typical neuroleptic drugs and affinity for dopamine D2 and serotonin 5-HT2A receptors — a new analysis of data from the archives and implications for improved antimanic treatments.
Journal of Psychopharmacology,
Vol. 23,
Issue. 8,
p.
899.
Nakic, Marina
Krystal, John H.
and
Bhagwagar, Zubin
2010.
Bipolar Disorder.
p.
210.
Rintamäki, Reeta
and
Partonen, Timo
2011.
Handbook of Behavior, Food and Nutrition.
p.
565.
Kapusta, Nestor D.
Mossaheb, Nilufar
Etzersdorfer, Elmar
Hlavin, Gerald
Thau, Kenneth
Willeit, Matthäus
Praschak-Rieder, Nicole
Sonneck, Gernot
and
Leithner-Dziubas, Katharina
2011.
Lithium in drinking water and suicide mortality.
British Journal of Psychiatry,
Vol. 198,
Issue. 5,
p.
346.
Smith, Daniel J.
Whitham, Elizabeth A.
and
Ghaemi, S. Nassir
2012.
Neurobiology of Psychiatric Disorders.
Vol. 106,
Issue. ,
p.
251.
Young, Allan H
2014.
Lithium and suicide.
The Lancet Psychiatry,
Vol. 1,
Issue. 6,
p.
483.
Suzuki, Hisaomi
Ohgidani, Masahiro
Kuwano, Nobuki
Chrétien, Fabrice
Lorin de la Grandmaison, Geoffroy
Onaya, Mitsumoto
Tominaga, Itaru
Setoyama, Daiki
Kang, Dongchon
Mimura, Masaru
Kanba, Shigenobu
and
Kato, Takahiro A.
2019.
Suicide and Microglia: Recent Findings and Future Perspectives Based on Human Studies.
Frontiers in Cellular Neuroscience,
Vol. 13,
Issue. ,
Corsi, Sara
Stancampiano, Roberto
and
Carta, Manolo
2021.
5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance - Part B.
Vol. 261,
Issue. ,
p.
287.